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Cyclic di-GMP (c-di-GMP) is a broadly conserved, intracellular second-messenger molecule that regulates
biofilm formation by many bacteria. The synthesis of c-di-GMP is catalyzed by diguanylate cyclases (DGCs)
containing the GGDEF domain, while its degradation is achieved through the phosphodiesterase activities of
EAL and HD-GYP domains. c-di-GMP controls biofilm formation by Pseudomonas fluorescens Pf0-1 by pro-
moting the cell surface localization of a large adhesive protein, LapA. LapA localization is regulated post-
translationally by a c-di-GMP effector system consisting of LapD and LapG, which senses cytoplasmic
c-di-GMP and modifies the LapA protein in the outer membrane. Despite the apparent requirement for
c-di-GMP for biofilm formation by P. fluorescens Pf0-1, no DGCs from this strain have been characterized to
date. In this study, we undertook a systematic mutagenesis of 30 predicted DGCs and found that mutations in
just 4 cause reductions in biofilm formation by P. fluorescens Pf0-1 under the conditions tested. These DGCs
were characterized genetically and biochemically to corroborate the hypothesis that they function to produce
c-di-GMP in vivo. The effects of DGC gene mutations on phenotypes associated with biofilm formation were
analyzed. One DGC preferentially affects LapA localization, another DGC mainly controls swimming motility,
while a third DGC affects both LapA and motility. Our data support the conclusion that different c-di-GMP-
regulated outputs can be specifically controlled by distinct DGCs.
Upon contacting a surface, bacteria can initiate behavioral
adaptations that result in the colonization of that surface. This
process, known as biofilm formation, occurs on surfaces in
environmental, industrial, and medical settings (7). While
there has long been evidence that bacteria regulate adhesion to
surfaces in response to internal and external cues, such as the
nutritional status of the cell (15, 35) or the availability of
nutrients in the environment (2, 24, 39, 48), we are just begin-
ning to understand how bacteria integrate these signals to
control the process of attachment (27).
Recent studies have highlighted the dinucleotide second
messenger cyclic di-GMP (c-di-GMP) as a central player in the
signaling networks that control biofilm formation. c-di-GMP is
synthesized from two GTP molecules by diguanylate cyclases
(DGCs), which contain the GGDEF domain (38, 42). The
degradation of c-di-GMP is achieved by phosphodiesterases
(PDEs) containing either the EAL (5, 44) or HD-GYP domain
(41). A number of proteins contain both GGDEF and EAL
domains but typically show either DGC or PDE activity only.
Individually or in tandem, GGDEF and EAL domains ap-
pear in combination with diverse regulatory domains com-
monly found in bacterial signaling proteins (9, 45). Regulatory
domains can control the synthesis or degradation of c-di-GMP
in response to light (49), oxygen (43, 50), or through posttrans-
lational modifications, such as phosphorylation by histidine
kinases (37, 40). Thus, many DGCs and PDEs are poised to
respond directly to environmental signals or cellular signaling
pathways.
Biofilm research has utilized P. fluorescens as a model, be-
cause growth on surfaces is a typical lifestyle for this bacterium
in nature and because its attachment to plant roots can pro-
mote plant growth (10). Exploring the environmental cues that
control the transition between planktonic and biofilm growth
for P. fluorescens has provided general insights into how bac-
teria regulate the switch between motile and sessile lifestyles.
An early study from our group identified a large adhesive
protein, LapA, required for the attachment of P. fluorescens to
surfaces (13). Subsequent investigations have detailed a c-di-
GMP signaling system that regulates biofilm formation via the
posttranslational modification of the LapA adhesin. Briefly,
the periplasmic protease LapG inhibits attachment by cleaving
the LapA protein and promoting the release of this adhesin
from the cell surface (31). LapG’s activity is regulated by an
inner membrane protein, LapD, which binds c-di-GMP in the
cytoplasm (33). c-di-GMP binding to LapD results in a con-
formational change that is propagated across the inner mem-
brane by a HAMP signaling module to LapD’s periplasmic
domain (29). When bound to c-di-GMP, LapD is capable of
binding the periplasmic protease LapG, inhibiting LapA cleav-
age and thereby promoting the retention of LapA on the cell
surface.
While we have a detailed picture of how the LapD-LapG
system regulates surface attachment by P. fluorescens Pf0-1 in
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response to c-di-GMP, much less is known about inputs that
modulate c-di-GMP in this signaling system. The one input
characterized to date is the depletion of c-di-GMP by RapA, a
PDE that is conditionally expressed in response to phosphate
starvation (24). No DGCs had been described in the Pf0-1
strain prior to this study, leaving open the issue of which
signaling proteins produce c-di-GMP that is sensed by LapD.
We set out to identify the DGCs required for biofilm formation
by this organism and determined their contribution(s) to bio-
film formation. Here, we report that of 30 predicted DGCs in
P. fluorescens Pf0-1, mutations to 4 cause significant reductions
in biofilm formation under the conditions tested. One DGC
preferentially affects LapA localization, another DGC mainly
controls swimming motility, while a third affects both LapA
and motility. The data presented argue for specificity in the
outputs controlled by certain DGCs.
MATERIALS AND METHODS
Strains and media. Strains and plasmids used in this study are listed in Table
S1. P. fluorescens Pf0-1 and Escherichia coli S17-1 (pir) strains were used
throughout this study. The SMC 4798 strain of Pf0-1, which carries three hem-
agglutinin (HA) epitope tags within a fully functional, chromosomally encoded
LapA, is designated wild-type (WT) P. fluorescens in this study. Bacteria were
routinely cultured with liquid LB medium in a test tube or on solidified LB with
1.5% agar. Gentamicin (Gm) was used at 30 g/ml for P. fluorescens and at 10
g/ml for E. coli. Ampicillin (Ap) was used at 50 g/ml for culturing E. coli cells
harboring pET vectors. Tetracycline (Tet) was used at 45 g/ml when growing P.
fluorescens on plates, 15 g/ml in liquid, and 10 g/ml for E. coli. For comple-
mentation and overexpression studies, arabinose was used to induce expression
from pMQ72 at the concentrations noted in the text. P. fluorescens was grown in
K10T-1 medium for assaying biofilm formation, LapA localization, and protein
abundance. This medium, used in prior studies as a phosphate-rich condition,
contains 50 mM Tris-HCl (pH 7.4), 0.2% (wt/vol) Bacto tryptone, 0.15% (vol/
vol) glycerol, 0.6 mM MgSO4, and 1 mM K2HPO4 and was prepared as described
previously (25).
Transposon mutagenesis and transposon mutation mapping. The pUT plas-
mid harboring miniTn5-KmlacZ1 was used to generate transposon insertions in
the chromosome of P. fluorescens Pf0-1. Transposon insertions were mapped
using arbitrarily primed PCR. Mutagenesis and mapping were performed exactly
as described previously (25).
Microarray experiment. Details concerning the microarray experiment de-
scribed here can be found in the supplemental material.
Biofilm formation assay. An aliquot (1.5 l) of an overnight culture grown in
LB was transferred into 100 l of K10T-1 medium in a 96-well plate (353911; BD
Falcon) and grown statically for 6 h at 30°C. After incubation, the cells were
discarded and material attached to the wells was stained with a 0.1% solution of
crystal violet (CV) in water. Staining, imaging, and quantification of attached
biomasses were performed as described previously (24).
Swimming motility assay. For swimming motility assays, K10T-1 plates con-
taining 0.35% agar were prepared by adding each filter-sterilized component of
K10T-1 medium to an autoclaved, molten agar solution. After solidifying for 3 h,
plates were inoculated with overnight cultures using sterile, 2- to 200-l micropi-
pette tips. For each point of inoculation, a fresh tip was dipped into 100 l of
culture in a 96-well plate and then plunged into the swim agar to the bottom of
the petri plate. After incubation at 30°C for 40 h, plates were photographed.
Each plate contained at least two replicates of the WT in addition to mutant
strains; the swim area was calculated using ImageJ software (http://rsbweb.nih
.gov/ij/) by encircling each swim zone with an oval selection and measuring its
area.
Construction of single-crossover knockouts. To construct the single-crossover
knockouts,500-bp PCR fragments of the N-terminal portion of each gene were
amplified and cloned into the pKO3 vector (Tetr) after digestion with appropri-
ate restriction enzymes (noted in primer sequences; all primers are listed in
Table S2 in the supplemental material). Each pKO3 plasmid was transformed
into E. coli S17-1 for conjugation with P. fluorescens Pf0-1, and conjugation was
performed at 30°C for 5 h on an LB plate without antibiotics as described
previously (25). P. fluorescens transconjugates were selected on plates containing
45 g/ml Tet and 30 g/ml chloramphenicol (Cm) to eliminate E. coli and
subsequently passaged in 15 g/ml Tet for liquid culture and 30 g/ml Tet on
solid plates. The proper location of each insertion was confirmed by PCR using
a primer that anneals to the vector backbone (pKO3 verify) and one targeting the
chromosomal DNA outside the initial amplicon (XXXX verify [where XXXX
represents the designated gene name]).
Constructs for clean deletion, complementation, and overexpression of DGCs.
Saccharomyces cerevisiae strain InvSc1 (Invitrogen) was used to construct plas-
mids for clean deletions and complementation and overexpression studies
through in vivo homologous recombination as described previously (46). All
deletion mutants were constructed using the same basic strategy: 1-kbp PCR
fragments were amplified from upstream and downstream of the gene to be
deleted. The fragments were cloned adjacent to each other in the allelic ex-
change vector pMQ30. Deletion constructs were introduced into P. fluorescens by
conjugation, and transconjugates were selected for on 30 g/ml Gm and 30 g/ml
Cm plates. Gm-resistant colonies were subcultured in the absence of antibiotic
and then subjected to selection on 5% sucrose. The deletion of the target genes
was confirmed by PCR across the area of recombination and subsequent se-
quencing of the PCR product.
Complementation and overexpression studies utilized the pMQ72 plasmid,
which contains the araC gene and a PBAD promoter directed toward the cloned
insert. This plasmid does not include a ribosomal binding site (RBS). Target
genes were amplified by PCR using primers that included the native RBS. The
basal expression of different genes from pMQ72 varies due to the use of each
gene’s native RBS. For GcbA, a 6 histidine (6His) tag was added to the
N-terminal end, while a C-terminal HA tag was utilized for GcbC and C-terminal
6His tags were used for GcbB and WspR. Site-directed mutations to GcbA
were made using the QuikChange site-directed mutagenesis kit (Stratagene, La
Jolla, CA) by following the manufacturer’s instructions. Site-directed mutations
to all other constructs were made using the following strategy. Two fragments
were amplified by PCR from the WT complementation plasmid template using
a primer on the vector backbone (pMQ72 Fwd or pMQ72 Rev) and a primer
divergent from (and excluding) the codons for the two acidic residues in the
GGDEF signature motif. Divergent primers included additional bases encoding
replacement alanine codons as well as sequence to facilitate recombination in
yeast. The transformation of yeast with pMQ72 and both PCR fragments yielded
a recombined plasmid identical to the parent except for the desired mutations.
The successful construction of each plasmid and each chromosomal alteration
was confirmed by sequencing.
Construction of pET expression vectors, expression and purification of en-
zymes. GcbA and variants were cloned from pMQ72 into pET3a by PCR am-
plification, restriction digestion, and ligation. Two primers, pET-Pfl01_0623 fwd
and P729, were used to produce the gene fragment possessing N-terminal NdeI
and C-terminal BamHI sites. After digestion of the PCR product and pET3a
with NdeI and BamHI, these pieces were ligated with T4 DNA ligase (New
England BioLabs, Beverly, MA).
The GcbA proteins with the N-terminal 6His tag were expressed in E. coli
BL21(DE3). Six hundred l of overnight culture was inoculated into 300 ml of
LB medium in a 2-liter flask, which was cultured at 37°C with gentle shaking (100
rpm). After 4.5 h the temperature was set to 28°C, and 0.5 mM isopropyl
-D-1-thiogalactopyranoside (IPTG) was added to the culture to induce protein
expression. Cultivation was continued for an additional 20 h, and then the cells
were harvested by centrifugation. The cells were stored at 80°C until use.
The frozen E. coli cells were resuspended in a binding buffer (75 mM Tris-HCl,
pH 7.8, 250 mM NaCl, 25 mM KCl, 10 mM MgCl2, 20% glycerol, 1 mM
dithiothreitol [DTT], and 20 mM imidazole) containing a protease inhibitor
cocktail (Roche) and then sonicated on ice. After centrifugation at 19,000 rpm
for 30 min, the supernatant was separated on a 5-ml-bed-volume HisTrap FF
column (GE Healthcare, Piscataway, NJ). The column was extensively washed
with the binding buffer. The absorbed proteins were eluted with the buffer
containing 200 mM imidazole. Protein was collected and dialyzed against the
DGC reaction buffer, which is described below. The purity of the protein was
checked by SDS-PAGE using 7% polyacrylamide gels stained with Coomassie
brilliant blue (CBB).
Hybrid DGC proteins were constructed by fusing GGDEF domains from
GcbB (D637 to the C terminus) or GcbC (D342 to the C terminus) to the N
terminus of GcbA after residue R377. This was accomplished by amplifying the
appropriate gene fragments by PCR with primers containing nonannealing bases
to direct homologous recombination with the adjacent fragment and pMQ72 via
in vivo recombination. The growth regimen (timing of induction, etc.) and sub-
sequent purification procedures (described above for GcbA) were employed for
the hybrid DGC constructs, except that arabinose was used as the inducer.
Diguanylate cyclase assay. In vitro diguanylate cyclase assays were performed
as described by Paul et al. (38) with slight modifications. Glycerol and DTT were
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added to the reaction mixture to avoid protein aggregation. Each purified protein
(200 g/3.1 nmol) was mixed with 1.66 nmol of [32P]GTP (3,000 Ci/mmol) to
initiate the reaction in a total volume of 50 l. Reactions were stopped by the
addition of 5 l 0.5 M EDTA. The reaction buffer contained 75 mM Tris-HCl,
pH 7.8, 250 mM NaCl, 25 mM KCl, 10 mM MgCl2, 20% glycerol, and 1 mM
DTT. Nucleotide reactants and products were separated by thin-layer chroma-
tography (TLC) as described previously (24) on cellulose PEI TLC plates (Se-
lecto Scientific, Suwanee, GA) with a running buffer of 1:1.5 saturated NH4SO4
and 1.5 M KH2PO4 (pH 3.6). Plates were exposed to a phosphor storage screen
and then read on a Storm 860 scanner (Molecular Devices, Sunnyvale, CA). The
effect of acetyl phosphate on the enzymatic activity was assayed by addition to a
final concentration of 10 mM in the reaction buffer.
Measurement of c-di-GMP levels. Nucleotide extraction from P. fluorescens
cultures was performed as previously reported (26), with modifications. Briefly,
an overnight, LB-grown culture was subcultured 1:75 into K10T-1 medium and
grown at 230 rpm for 6 h. Cells were harvested by centrifugation at 4°C for 5 min
at 8,000  g. Pellets were quickly resuspended in a small amount of supernatant,
transferred to a 1.5-ml microcentrifuge tube, and then pelleted again. After
completely removing the supernatant, pellets were resuspended in 250 l of
extraction buffer (acetonitrile-methanol-water [40:40:20] plus 0.1 N formic acid)
and incubated at 20°C for 24 h. Cell debris was pelleted for 5 min at 4°C, and
resulting supernatant was adjusted to pH 7.5 by adding 15% (NH4)2HCO3.
Nucleotide extractions were dried under nitrogen gas at room temperature and
then resuspended in 10 mM tributylamine plus 15 mM acetic acid in water-
methanol (97:3). Resuspended samples were analyzed via an Acquity ultraper-
formance liquid chromatography (UPLC) system coupled to a Quattro Premier
XE mass spectrometer (Waters Corporation, Milford, MA). The mass spectrom-
etry (MS) parameters were the following: capillary voltage, 3.5 kV; cone voltage,
50 V; collision energy, 34 V; source temperature, 120°C; and desolvation tem-
perature, 350°C. UPLC separation was achieved using an Acquity UPLC BEH
C18 column (particle size, 1.7 m; 2.1 by 50 mm; Waters Corporation, Milford,
MA). Solvent A was 10 mM tributamine plus 15 mM acetic acid in water-
methanol (97:3), and solvent B was methanol. The gradient was the following:
time 0, 1% solvent B; 1 min, 1% solvent B; 2.5 min, 20% solvent B; 4 min, 20%
solvent B; 7 min, 65% solvent B; 7.5 min, 95% solvent B; 9 min, 95% solvent B;
9.01 min, 1% solvent B; 10 min, 1% solvent B. The running time for each sample
was 10 min. Other liquid chromatography parameters were the following: column
temperature, 50°C; and solvent flow rate, 300 l/min. Each sample was compared
to a standard curve of c-di-GMP resuspended in water to quantify the amount of
nucleotide.
Statistical methods. All statistical tests were performed in Excel (Microsoft
Corp., Redmond, WA). Unless noted otherwise in the text, the test employed
was a two-tailed, Student’s t test assuming equal variance.
Microarray accession number. Our microarray data and design information
were deposited in the GEO database under accession number GSE30681.
RESULTS
The genome of P. fluorescens Pf0-1 encodes 5 EAL, 21
GGDEF, and 17 tandem GGDEF/EAL domain proteins (47).
Despite ample evidence that c-di-GMP regulates biofilm for-
mation by this organism, to date no diguanylate cyclases have
been characterized in this strain. To identify DGCs that pro-
mote biofilm formation by P. fluorescens Pf0-1, we undertook a
transposon mutagenesis screen for biofilm-deficient mutants.
Approximately 14,600 transposon insertion mutants were
screened using a static-growth, microtiter dish assay. As with
our previous studies of P. fluorescens Pf0-1, we utilized K10T-1
medium, a dilute medium with 0.2% tryptone, as the primary
source of carbon and nitrogen (see Materials and Methods for
more information). We focused on this growth condition be-
cause our previous work showed that c-di-GMP signaling
through the effector protein LapD is required for biofilm for-
mation in this medium (33), and multiple lines of evidence in
previously published studies suggest that robust changes in
biofilm formation result from the modulation of c-di-GMP
levels under these conditions (24, 26, 29, 31).
A total of 145 mutants, about 1% of mutants tested, showed
a measurable reduction in biofilm formation. The location of
each transposon mutation yielding a reduced biofilm pheno-
type was identified by arbitrarily primed PCR and sequencing
(see Table S3 in the supplemental material). Mutations were
found in genes with a wide variety of predicted functions, with
mutations occurring most frequently in genes involved in fla-
gellar synthesis and modification or LapA production and reg-
ulation. About a third of the mutations were in one of the lap
genes and already have been characterized for their roles in
adhesion and biofilm formation (lapA, lapB, lapC, lapD, and
lapE) (13, 14). Other genes found in the screen which have
established roles in biofilm regulation include pstC (24) and
sadB (22). No putative exopolysaccharide synthesis loci were
identified, which is consistent with previous observations that
P. fluorescens Pf0-1 does not contain homologues of exopoly-
saccharide synthesis genes common to other pseudomonads
(32). When mutants with a more subtle reduction in biofilm
formation were characterized, one was found to contain a
transposon insertion in a putative diguanylate cyclase gene,
Pfl01_0623.
Putative DGC, GcbA, promotes biofilm formation. The
strain bearing a transposon insertion in Pfl01_0623 showed a
25% reduction in attached biomass in the static biofilm forma-
tion assay (Fig. 1A). To confirm the necessity of Pfl01_0623 for
the effect observed, an unmarked deletion of the gene was
constructed in a WT genetic background. The resulting strain
showed a reduction in biofilm biomass relative to that of the
WT that was comparable to that exhibited by the transposon
mutant (Fig. 1A). Given the reduced biofilm phenotype and
the predicted function of Pfl01_0623, we named the gene gcbA
(for di-guanylate cyclase promoting biofilm) and the deletion
mutant gcbA.
The gcbA gene encodes a protein with three predicted do-
mains: rec, REC, and GGDEF (Fig. 1B). The first receiver
domain is too degenerate to match the reference in the Con-
served Domain Database (CDD; http://ncbi.nlm.nih.gov
/Structure/cdd/cdd.shtml) but was predicted by the simple
modular architecture research tool (E 	 0.15; http://smart
.embl-heidelberg.de). The second receiver domain appears to
be well conserved (E 	 1  1027 according to the CDD) and
contains an aspartic acid residue at the expected phosphoryla-
tion site, D299. The predicted GGDEF domain of gcbA also is
well conserved (E	 3 1048 according to the CDD) and has
all residues known to be required for DGC activity in other
GGDEF domain proteins. A BLAST search identified genes
homologous to gcbA in other strains of P. fluorescens and other
Pseudomonas species, including P. syringae, P. putida, and P.
aeruginosa, each with more than 70% sequence identity. No
cognate histidine kinase was found in proximity to gcbA or its
homologues.
A genetic complementation analysis was utilized to test the
sufficiency of gcbA for the observed effects on biofilm forma-
tion and to test which residues of the GcbA protein are re-
quired for function in vivo. A WT copy of gcbA was placed
under the control of the PBAD promoter on a multicopy plas-
mid, pMQ72, and amended with an N-terminal 6His tag.
When introduced into the gcbA strain, this construct restored
WT biofilm formation, with the addition of 0.2% arabinose to
the assay medium (Fig. 1C). The empty vector did not restore
a WT biofilm phenotype to gcbA.
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To test if the putative phosphorylation site, D299, or the
GGDEF motif is necessary for GcbA function, we introduced
mutations into the complementation construct, generating al-
leles with D299A or GGDEF-to-GGAAF mutations. The re-
sulting constructs could not restore biofilm formation to the
gcbA strain (Fig. 1C). These results suggest that GcbA func-
tions as a DGC to promote biofilm formation through the
synthesis of c-di-GMP and imply that phosphorylation at res-
idue D299 is important for this activity.
Despite significant effort, we were unable to detect the ex-
pression of the His-tagged GcbA proteins, WT, or mutants in
P. fluorescens by Western blotting. Even attempts to concen-
trate the WT or mutant proteins by applying large volumes of
cell lysate to nickel resin failed to yield detectable protein. In
contrast, all three GcbA proteins were stable and soluble when
expressed in E. coli, as discussed below. Thus, while mutant
proteins did not show reduced stability in vitro, it is possible
that the D299A and GGAAF mutant alleles do not comple-
ment the gcbA strain because they are unstable in vivo.
gcbA inhibits swimming motility of P. fluorescens. One way
c-di-GMP promotes biofilm formation by P. fluorescens Pf0-1 is
by supporting the localization and maintenance of the LapA
adhesin on the cell surface via the c-di-GMP receptor LapD
(33). We assessed the effect of the gcbA mutation on LapA
localization to test the hypothesis that c-di-GMP generated by
GcbA promotes biofilm formation through this pathway. In-
terestingly, the deletion of gcbA had only a minor effect on cell
surface LapA levels (this phenotype is presented and discussed
below).
We next tested the hypothesis that c-di-GMP generated by
GcbA regulates another output: flagellar motility. In many
bacteria, c-di-GMP is known to inhibit flagellar motility, and
these effects often affect biofilm formation (52). We found that
the gcbA mutant swam through a larger area than the WT
strain when grown in 0.35% agar plates for 40 h (Fig. 1D). In
contrast, the complemented strain, gcbA pGcbA, covered an
area comparable to that of the WT strain. This indicates that
gcbA inhibits swimming motility under these conditions. Nei-
FIG. 1. Genetic characterization of gcbA. (A) A quantitative biofilm assay comparing the WT, Pfl01_0623 transposon mutant, and unmarked
gcbA deletion strains. Data presented are the mean absorbances of dissolved crystal violet-stained biofilm material
 standard deviations (SD) (n	
12). Representative images are shown above the graph. (B) A schematic of the GcbA protein showing the amino acid numbers and predicted
domains. The lowercase “rec” indicates a degenerate REC domain. (C) A quantitative biofilm assay examining the complementation of the gcbA
mutant biofilm phenotype. pMQ72 is the empty complementation vector; 0.2% arabinose was added to the medium. (D) A representative image
of a swimming motility assay in 0.35% agar assessing the complementation of the gcbA mutant. (E) Quantitative measurements of swim zone
areas are presented for eight replicates of the assay shown in panel D. Data presented are mean percentages of WT swim areas on the same plate

standard errors (SE) (n 	 8).
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ther the GGAAF nor the D229A allele of gcbA could comple-
ment the gcbA mutant in this assay, suggesting that functional
GGDEF and REC domains are required for GcbA’s effects on
swimming. A quantitative analysis of these swimming pheno-
types is presented in Fig. 1E.
Investigating connections between GcbA and the regulation
of biofilm formation by inorganic phosphate. Biofilm forma-
tion by P. fluorescens Pf0-1 is inhibited by phosphate starvation
via the induction of the Pho regulon (24). This response in-
cludes the Pho-induced expression of RapA, a phosphodies-
terase which depletes cellular c-di-GMP under phosphate-lim-
iting conditions (24). Our prior work indicated that RapA
accounts for most, but not all, of the observed Pho-dependent
reduction of biofilm formation. Thus, we were intrigued to
discover that gcbA is adjacent to ctpL (Pfl01_0622), a Pho-
regulated gene which was shown to act in chemotaxis toward
inorganic phosphate in P. aeruginosa (53) (see Fig. S1A in the
supplemental material for a diagram of the locus). To investi-
gate connections between this locus and the Pho-dependent
regulation of biofilm formation, we sought to confirm the Pho
regulation of ctpL in P. fluorescens Pf0-1, test if gcbA expres-
sion also is affected by the Pho system, and assess the effect of
mutations in ctpL and gcbA on the inhibition of biofilm for-
mation by phosphate limitation.
A microarray experiment was performed comparing gene
expression in the WT (Pho-off) to that of the pst mutant
(Pho-on) strains in high-phosphate medium. The expression
of ctpL was induced 7-fold in the Pho-on condition, while
gcbA expression was slightly reduced (see Tables S4 and S5
in the supplemental material). Only rapA, of all of the genes
encoding GGDEF and EAL domain proteins, showed dif-
ferential regulation of 2-fold in the microarray data set
(see Table S5). Despite evidence for Pho regulation at the
ctpL locus, the mutation of neither gcbA nor ctpL had any
effect on the inhibition of biofilm formation by phosphate
limitation (see Fig. S1B).
The GcbA protein exhibits DGC activity stimulated by phos-
phorylation. The genetic characterization of gcbA suggested
that it acts as a DGC. To test if the GcbA protein possesses
DGC activity, constructs were made in the conventional pET
expression system for WT, D299A, and GGAAF proteins, each
amended with an N-terminal 6His tag. We expressed and
purified proteins from E. coli and obtained yields of60 mg of
pure protein/liter of culture for each protein. The purity of
each protein was more than 90% as judged by Coomassie-
stained polyacrylamide gels (data not shown). No differences
in protein purity or stability (such as aggregation) were ob-
served between the WT and mutant proteins during purifica-
tion.
To test for DGC activity, WT or mutant GcbA was incu-
bated with [32P]GTP at room temperature for 16 h. These
assay conditions were chosen so that even weak in vitro DGC
activity could be detected. PleD* was used as a positive con-
trol, as previously published (38). Reactions were stopped by
the addition of EDTA to 50 mM and resolved by thin-layer
chromatography. As shown in Fig. 2A, both the WT and
D299A proteins converted GTP to c-di-GMP, while the
GGAAF mutant protein did not. These data show that GcbA
can act as a DGC, and that the GGDEF motif is required for
this activity while D299 is not.
To resolve the role of D299 in regulating GcbA activity, we
treated samples of the WT and D299A proteins with acetyl
phosphate, which can function to phosphorylate and activate
REC domain proteins in vitro (18). Using acetyl phosphate-
treated and untreated samples, we assayed the DGC activity of
WT and D299A proteins during shorter reaction times. We
found that acetyl phosphate-treated WT GcbA had elevated
DGC activity compared to that of the untreated control (Fig.
2B). In contrast, the acetyl phosphate treatment of the D299A
protein had no effect on its DGC activity, which was similar to
that of untreated WT protein (Fig. 2B). This experiment sug-
gests that the phosphorylation of GcbA stimulates its DGC
activity, and residue D299, in the REC domain proximal to the
GGDEF domain, is the likely site of phosphorylation. This
stands in contrast to PleD, which has a REC-REC-GGDEF
domain structure but is activated by the phosphorylation of the
first REC domain (37). Therefore, the activation mechanisms
of GcbA and PleD may be different even though they share
structural similarities.
Identification of additional GGDEF domain proteins that
promote biofilm formation. For P. fluorescens Pf0-1, mutations
that block c-di-GMP binding to LapD completely abolish bio-
film formation (33), implying that c-di-GMP is required for
biofilm formation. Given the partial loss of biofilm formation
exhibited by the gcbA mutant, we predicted that additional
DGCs act to promote biofilm formation by this organism. The
genome of P. fluorescens Pf0-1 encodes 37 putative GGDEF
domain proteins in addition to GcbA. Two of these proteins
were characterized in our laboratory, LapD (Pfl01_0131) and
RapA (Pfl01_1678), and do not possess DGC activity (24, 33).
Six other putative GGDEF domain proteins show signature
motif sequences that deviate from what is known to be re-
quired for DGC activity, and these were not investigated
(Pfl01_ 460, Pfl01_2295, Pfl01_4487, Pfl01_4552, Pfl01_5581,
FIG. 2. Enzymatic characterization of GcbA. (A) In vitro DGC
assays comparing GcbA and mutant variants to the control DGC,
PleD*, are shown resolved on a thin-layer chromatography plate.
Compounds are labeled on the left; the image was generated by a
phosphor screen scanner. (B) Assay comparing the effect of acetyl-
phosphate (AcPi) treatment on the DGC activity of WT GcbA and the
D299A mutant.
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and Pfl01_5643), leaving 29 candidate DGCs in addition to
GcbA (Table 1).
To investigate their potential roles in biofilm formation,
each gene encoding a candidate DGC was inactivated by sin-
gle-crossover disruption, and the resulting mutant was com-
pared to the WT in a static biofilm assay. A single-crossover
mutation in gcbA was utilized for comparison. Most of the
mutants exhibited biofilm formation levels comparable to that
of the WT strain (Fig. 3A). Mutations in five genes showed
statistically significant increases in biofilm formation compared
to that of the WT (P  0.01): Pfl01_0192, Pfl01_1887,
Pfl01_2709, Pfl01_4086, and Pfl01_4876. Mutations in four
genes caused significant (P  0.01) reductions in biofilm for-
mation compared to that of the WT in a two-tailed Student’s t
test assuming equal variance (for details on statistical methods,
see Materials and Methods): the strain carrying a single-cross-
over mutation in gcbA, Pfl01_0623KO, showed a 27% reduc-
tion (P 	 7.5  108); Pfl01_1058KO showed an 11% reduc-
tion (P	 6.8 103); Pfl01_1789KO showed a 27% reduction
(P 	 8.5  107); and Pfl01_4666KO showed a 15% reduction
(P 	 1.8  103).
From these results we hypothesized that, in addition to gcbA,
genes Pfl01_1058, Pfl01_1789, and Pfl01_4666 also encode
DGCs that promote biofilm formation. Unmarked deletions of
the entire open reading frames of these three new candidate
genes were constructed in the WT background. A biofilm assay
on the resulting mutant strains confirmed the necessity of
Pfl01_1058, Pfl01_1789, and Pfl01_4666 for achieving WT lev-
els of biofilm formation (Fig. 3B).
Following the nomenclature introduced for GcbA, Pfl01_
1789 and Pfl01_4666 were dubbed gcbB and gcbC, respectively.
Pfl01_1058 encodes a homologue of the well-characterized
DGC WspR. WspR can regulate pellicle formation by P. fluo-
rescens SBW25 and biofilm formation by P. aeruginosa PAO1
through the synthesis of c-di-GMP (12, 20). Pfl01_1058 shares
90 and 75% amino acid identity with the SBW25 and PAO1
WspR proteins, respectively, and amino acid sequence align-
ments performed by De et al. suggest the complete conserva-
tion of important structural and functional features in
Pfl01_1058 (8). We refer to Pfl01_1058 as wspR.
Complementation analysis of wspR. To investigate the role
of WspR in biofilm formation by P. fluorescens Pf0-1, we con-
ducted a complementation analysis. We constructed a C-ter-
minally 6His-tagged allele of wspR and also a variant of this
allele containing the GGAAF mutation in the signature motif.
The introduction of pWspR-6H into the wspR strain restored
biofilm formation to WT levels, while pWspR-GGAAF did not
(Fig. 4A). Both WT and mutant WspR proteins had compa-
TABLE 1. Putative diguanylate cyclases investigated in this study
Locus tag Name or homologuea DGC motifb PDE motif Other domain(s)c Biofilm phenotyped Mutatione
Pfl01_0050 GGEEF No change Insertion
Pfl01_0190 GGEEF PAS 3 No change Insertion
Pfl01_0192 GGDEF EAL TM, PAS Increased Insertion
Pfl01_0623 GcbA GGDEF REC Decreased Deletion, Tn
Pfl01_0692 AwsR/YfiN (19, 21) GGDEF TM, HAMP No change Insertion
Pfl01_1058 WspR (12, 20) GGEEF REC Decreased Insertion
Pfl01_1252 SwsR (21) GGDEF EAL TM, MHYT No change Insertion
Pfl01_1323 GGDEF PAS 3, GAF No change Insertion
Pfl01_1336 GGEEF TM No change Insertion
Pfl01_1789 GcbB GGEEF TM, CHASE, PAS Decreased Deletion
Pfl01_1887 GGDEF EAL PAS, PAS 3, PAS 4 Increased Insertion
Pfl01_2049 Similar to AdrA (16) GGDEF MASE2, TM No change Insertion
Pfl01_2170 GGDEF 7 TM No change Insertion
Pfl01_2176 GGDEF GAF No change Insertion
Pfl01_2297 GGEEF TM, CACHE_1 No change Insertion
Pfl01_2525 Similar to MucR (11) GGDEF EAL TM, MHYT No change Insertion
Pfl01_2709 GGDEF EAL TM, CHASE4, PAS Increased Insertion
Pfl01_3508 GGDEF TM, PAS 3 No change Insertion
Pfl01_3550 GGDEF TM, HAMP No change Insertion
Pfl01_3800 GGDEF TM No change Insertion
Pfl01_4084 GGEEF No change Deletion
Pfl01_4086 RbdA (1) GGDEF EIL TM, PAS Increased Insertion
Pfl01_4307 GGDEF MASE2, TM No change Insertion
Pfl01_4451 Similar to SadC (22) GGDEF 7 TM No change Insertion
Pfl01_4551 GGDEF aaq PAS, PAC, REC No change Insertion
Pfl01_4666 GcbC GGEEF TM, CACHE_1 Decreased Deletion
Pfl01_4876 MwsR/MorA (4, 21) GGDEF EAL TM, PAS Increased Insertion
Pfl01_5150 GGDEF EAL SBP bac3, TM, PAS No change Insertion
Pfl01_5168 GGEEF 7 TM No change Insertion
Pfl01_5255 GGDEF EAL REC, PAS No change Insertion
a Names for DGCs characterized in this study, or homologues (65% amino acid identity) that have been characterized in other organisms, are given with references
indicated. “Similar to” indicates 65% amino acid identity but similar domain structures.
b Amino acid sequences at the signature GGDEF and EAL motifs are given. Lowercase letters indicate degenerate sequence, and boldface letters indicate phenotypic
evidence suggesting the domain is enzymatically active in P. fluorescens Pf0-1.
c Other predicted domains are indicated using Pfam symbols (http://pfam.sanger.ac.uk/).
d Biofilm phenotypes are given relative to that of WT P. fluorescens Pf0-1 in K10T-1 medium.
e The type of mutant(s) tested for each locus is given: Tn, Tn5 insertion; insertion, single-crossover insertion of pKO3; deletion, unmarked deletion of the entire gene.
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rable levels of expression in vivo (Fig. 4B). These data support
the conclusion that WspR acts as a DGC to promote biofilm
formation by P. fluorescens Pf0-1. Consistent with the small
reduction in biofilm formation by the wspR mutant, it had
limited phenotypic effects on biofilm-associated phenotypes
such as LapA localization and swimming motility under the
conditions tested (see below).
Complementation analysis of gcbB. The deletion of the gcbB
gene caused a decrease in biofilm formation on par with that of
the gcbA mutation (Fig. 3B). The gcbB gene is predicted to
encode a membrane-localized DGC with an extracellular
CHASE domain and intracellular PAS domains (Fig. 5A). A
BLASTP search with the GcbB sequence returns 21 homolo-
gous proteins (70% similarity across the whole sequence) in
strains of P. fluorescens, P. putida, and P. syringae. We tested
the ability of WT GcbB bearing a C-terminal 6His tag and a
GGAAF mutant allele to complement the gcbB mutation.
We first confirmed that both WT and GGAAF proteins were
expressed in vivo, where the GGAAF protein was slightly more
abundant than the WT (Fig. 5B).
We next assessed the ability of these constructs to restore
biofilm formation to gcbB. For this experiment we utilized the
arabinose-inducible PBAD promoter on the pMQ72-based
FIG. 4. Complementation analysis of wspR. (A) A quantitative bio-
film assay examining the complementation of the wspR mutant phe-
notype; 0.1% arabinose was added to the medium. (B) Western blot
comparing the abundance of WspR-6H and WspR-GGAAF proteins
in vivo. Samples were probed for the 6His epitope on each protein,
and cells were cultured in K10T-1 with 0.1% arabinose.
FIG. 3. Effect of mutations in putative DGCs on biofilm formation. (A) A quantitative biofilm assay analyzing the WT and single-crossover
insertion mutants in gcbA and 29 putative DGCs; data are mean percentages of the WT 
 SD (n 	 8). Asterisks indicate a statistically significant
decrease in biofilm relative to that of the WT (P  0.01 in a two-tailed Student’s t test assuming equal variance). (B) A quantitative biofilm assay
comparing the WT and strains with deletion mutations of Pfl01_0623 (gcbA), Pfl01_1789 (gcbB), Pfl01_4666 (gcbC), and Pfl01_1058 (wspR).
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complementation constructs, which can increase expression
when arabinose is added (46). Without the addition of arabi-
nose, pGcbB-6H provided a partial restoration of biofilm for-
mation, but with the addition of 0.01% arabinose to the me-
dium, biofilm formation by gbcB pGcbB-6H was comparable
to that of the WT strain (Fig. 5C). This stands in contrast to the
empty vector, pMQ72, and the pGcbB-GGAAF construct,
which could not complement the gcbB mutant even with the
addition of arabinose. When the highest concentration of arabi-
nose was added to the medium, 0.1%, the gcbB pGcbB-6H
strain formed more biofilm than the WT, while the vector and
pGcbB-GGAAF construct still had no effect on biofilm forma-
tion by gcbB (Fig. 5C).
In previous studies of P. fluorescens Pf0-1, we have observed
a close correspondence between the amount of cell surface
LapA adhesin and the level of biofilm formation in a static
microtiter dish assay (24, 26, 33). Biofilm formation by Pf0-1
relies on the adhesin LapA, whose localization to and mainte-
nance on the outer membrane is tightly controlled by c-di-
GMP via the LapDG effector system (31). The cell surface
LapA localization assay consists of drying washed cells onto a
nitrocellulose membrane and immunoblotting with an anti-
body directed toward the HA epitope on the LapA protein.
This assay detects only extracellular LapA that is tightly asso-
ciated with the cell surface, as shown previously (33).
We examined the impact of gcbB on cell surface LapA lo-
calization and found that the gcbB strain carrying the empty
vector exhibited a reduction in cell surface LapA compared to
that of the WT (Fig. 5D). The pGcbB-6H construct could
restore WT levels of cell surface LapA to gcbB, while the
pGcbB-GGAAF construct could not (Fig. 5D). These data are
consistent with GcbB acting as a DGC in vivo and promoting
biofilm formation through the cell surface localization of
LapA.
Complementation analysis of the DGC gcbC. gcbC encodes a
protein predicted to contain two transmembrane domains, a
periplasmic CACHE_1 superfamily domain and a cytoplasmic
GGDEF domain (Fig. 6A). A BLASTP search identified 20
proteins likely to be homologues of GcbC (65% amino acid
similarity over the whole sequence) encoded in genomes of
environmental pseudomonads as well as other bacteria. We
performed a complementation analysis to determine if gcbC
was sufficient to account for the gcbC mutant phenotype and
assess if the GGDEF motif is important for GcbC function.
We built expression constructs for WT and GGAAF mutant
alleles of gcbC, incorporating a C-terminal HA tag to track
protein abundance in vivo. In the gcbC strain, the GcbC-HA
and GcbC-GGAAF proteins were expressed at comparable
levels, with the GcbC-GGAAF protein consistently showing
slightly higher abundance (Fig. 6B). The addition of
pGcbC-HA to gcbC led to an increase in biofilm above WT
levels (Fig. 6C). When arabinose was added to induce a higher
level of expression of GcbC-HA, biofilm formation was in-
creased to nearly twice the level of the WT. To our surprise,
the addition of pGcbC-GGAAF to gcbC restored biofilm
formation to nearly WT levels despite the mutation to the
GGDEF domain (Fig. 6C). However, the overexpression of
GcbC-GGAAF with arabinose showed no stimulatory effect on
biofilm formation.
We examined the effect of the gcbC mutation on LapA
localization and swimming motility and assessed the comple-
mentation of these phenotypes by wild-type and mutant gcbC
FIG. 5. Complementation analysis of gcbB. (A) A schematic of the GcbB protein showing the amino acid numbers (above) and predicted
domains in boxes. TM, transmembrane. (B) Western blot comparing the abundance of GcbB-6H and GcbB-GGAAF proteins in vivo. Samples
were probed for the 6His epitope on each protein, and cells were cultured in K10T-1 with 0.01% arabinose. (C) A quantitative biofilm assay
examining the complementation of the gcbB mutant phenotype by pGcbB-6H and pGcbB-GGAAF at three concentrations of inducer (ara,
arabinose). (D) A quantitative immunoblot assay probing whole cells for the surface expression of LapA. Pixel densities of blot images were
calculated using ImageJ, and the mean density for the WT was set to 100. Data shown are means 
 SE (n 	 7). Representative images are shown
above the graph.
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expression constructs. The gcbC mutant carrying an empty
vector exhibited a substantial decrease in LapA expression on
the cell surface (Fig. 6D) and increased swimming motility
compared to that of the WT strain (Fig. 6E). Similarly to the
results for complementation in the biofilm assay, the gcbC
pGcbC-HA strain showed a gain of function: increased
LapA-HA localization and reduced motility compared to those
of the WT (Fig. 6D to F). While pGcbC-GGAAF had shown
some ability to promote biofilm formation (Fig. 6C), its effect
on the gcbC mutant’s LapA localization and swimming phe-
notypes was less pronounced, showing a small but measurable
increase above the level for the empty vector control (Fig. 6D
to F). The complementation data set is consistent with GcbC
acting as a DGC to promote biofilm formation; GcbC’s DGC
activity likely is required to support the surface localization of
LapA and also may inhibit motility. The basis for the partial
complementation of the biofilm phenotype of gcbC by the
GcbC-GGAAF mutant construct is unclear at this time. The
complementation phenotype observed for GcbC-HA was iden-
tical to that of an untagged gcbC allele in pMQ72 (data not
shown).
Assessing DGC activity of GcbB and GcbC. We took several
approaches to investigate whether or not GcbB or GcbC pos-
sesses DGC activity. The first was to purify full-length versions
of each protein by nickel affinity chromatography and assess
their activity in vitro. The addition of a C-terminal 6His tag to
full-length GcbC resulted in a loss of function and stability in
vivo (data not shown), so this construct was not pursued fur-
ther. Full-length, 6His-tagged GcbB was stably expressed in
E. coli and could be purified in 1% Thesit or Triton X-100.
These preparations did not exhibit DGC activity in vitro (data
not shown).
As an alternative strategy, we constructed hybrid proteins in
which the GGDEF domains from either GcbB or GcbC were
fused to the N terminus of GcbA, replacing its native GGDEF
domain. A similar strategy was successfully employed by our
FIG. 6. Complementation analysis of gcbC. (A) A schematic of the GcbC protein showing the amino acid numbers and predicted domains in
boxes. TM, transmembrane. (B) Western blot comparing the abundance of GcbC-HA and GcbC-GGAAF proteins in vivo. Samples were probed
for HA on each protein, and cells cultured in K10T-1 without arabinose. (C) A quantitative biofilm assay examining the complementation of the
gcbC mutant phenotype by pGcbC-HA and pGcbC-GGAAF with and without inducer (ara, arabinose). (D) A quantitative immunoblot assay
probing whole cells for the surface expression of LapA. Data shown are means 
 SE (n 	 7). Representative images are shown above the graph.
(E) A representative image of a swimming motility assay in 0.35% agar, assessing the complementation of the gcbC mutant. (F) Quantitative
measurements of swim zone areas are presented for eight replicates of the assay shown in panel E. Data presented are mean percentages of WT
swim area on the same plate 
 SE (n 	 8).
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laboratory in the past, fusing the N terminus of PleD to
GGDEF domains from other membrane proteins (22, 23).
Site-directed GGAAF mutant forms of these constructs also
were made.
The hybrid proteins were expressed and purified in the same
manner as that for the GcbA protein. While we were able to
purify hybrid proteins containing the GGDEF domain of
GcbB, they did not show DGC activity in vitro (data not
shown). In contrast, the GcbC-Hyb protein was able to pro-
duce c-di-GMP in vitro, while the GGAAF mutant form was
not (Fig. 7A). This indicates that the GGDEF domain of GcbC
is enzymatically active and supports the idea that GcbC acts as
a DGC in vivo.
To provide further evidence that GcbB and GcbC act as
DGCs in vivo, we measured the impact of each protein and its
GGAAF mutant on cellular c-di-GMP levels by acid extraction
followed by LC/MS (23). This experiment was performed using
the 4DGC strain lacking four DGCs (gcbA, gcbB, gcbC, and
wspR) to enable robust changes in cellular c-di-GMP to be
observed (the 4DGC mutant phenotype is discussed below).
The expression of each construct was induced using the con-
centration of arabinose that had previously resulted in WT
complementation phenotypes in the single-mutant strains:
0.01% arabinose for pGcbB constructs and no arabinose for
pGcbC constructs. The expression of GcbB-6H boosted cellu-
lar c-di-GMP 1.6-fold compared to that of GcbB-GGAAF
(Fig. 7B; P 	 0.001 in one-tailed Student’s t tests; n 	 3).
Likewise, the expression of GcbC-HA in the 4DGC strain
caused a 2.2-fold increase in cellular c-di-GMP compared to
that of GcbC-GGAAF in the same strain (Fig. 7B; P 	 0.0002
in one-tailed Student’s t tests; n	 3). There were no significant
changes in c-di-GMP levels due to the expression of either
GcbB-GGAAF or GcbC-GGAAF compared to that of a vec-
tor-only control strain (Fig. 7B; P 	 0.35 and P 	 0.19, respec-
tively). Taken together, these data reinforce the conclusion
that GcbB and GcbC act as DGCs in vivo.
Combinatorial effects of DGC mutations on biofilm forma-
tion. An intriguing question in c-di-GMP research is the fol-
lowing: to what extent do different c-di-GMP signaling proteins
form distinct pathways in the same cell? As an initial step
toward addressing this question, we undertook a combinatorial
mutant analysis of the four DGCs identified here. Our goal was
to assess whether the effects of combined mutations were ad-
ditive across all phenotypes assessed or if one or more DGC
had a disproportionate effect on a particular phenotype.
Beginning with strains bearing an unmarked deletion in each
DGC, we constructed each combination of double- and triple-
deletion mutants, as well as a quadruple-deletion mutant lack-
ing all four DGC genes. The full panel of deletion mutants was
tested for biofilm formation and compared to the WT (Fig.
8A). The biofilm reductions that resulted from single deletions
of gcbA, gcbB, and gcbC were roughly additive when these
mutations were combined in double and triple mutants.
Interestingly, mutations to wspR did not yield additive phe-
notypes in double and triple mutants. Some double mutants
that include wspR showed a reduction compared to that of
their single-mutant parent strain (gcbA wspR or gcbC
wspR), but these reductions were less than an additive rela-
tionship would predict (Fig. 8A). The gcbB wspR double
mutant showed no additional reduction in biofilm compared to
the level for the gcbB single mutant. Furthermore, each triple
mutant incorporating wspR showed no additional reduction
in biofilm formation relative to that of the wspR parent strain
(Fig. 8A). On the other hand, the quadruple deletion mutant
showed a measurable reduction in biofilm relative to that of
the wspR triple mutant. Taken together, these data show that
most DGC mutations affect biofilm formation in an additive
manner, while the effect of deleting wspR is apparent only in
single- and quadruple-mutant backgrounds.
Effect of DGC gene deletions on LapA localization. We an-
alyzed the effects of each DGC deletion mutation, and some
combination mutations, on LapA localization to the cell sur-
face to assess how they affect this c-di-GMP-regulated output.
Compared to the WT, each DGC mutant showed some reduc-
tion in cell surface LapA (Fig. 8B), while levels of the LapA
protein did not differ in whole-cell lysates of any of the strains
analyzed (data not shown). The wspR and gcbA mutations
resulted in mild reductions in LapA that were not statistically
significant (P 	 0.57 and P 	 0.41, respectively). The gcbC
and gcbB mutations caused more severe reductions, 38 and
48%, respectively, that were significant (P  0.005).
We included two double mutants and the 4DGC mutant in
the analysis. Our rationale was to combine the two mutations
with the smallest effect on LapA, gcbA wspR, and those with
the largest effect, gcbB gcbC. In combination, the mild ef-
FIG. 7. In vitro and in vivo assessments of DGC activity. (A) In vitro
DGC assays comparing GcbC-Hyb and GcbC-Hyb-GGAAF mutant
variants to GcbA as a positive control. An image of a thin-layer chro-
matography plate generated by a phosphor screen scanner is shown
with compounds labeled on the left. (B) Quantitative measurements of
cellular c-di-GMP from the 4DGC strain expressing the indicated
plasmids. Formic acid-extracted c-di-GMP was measured by LC/MS
and normalized to mg of dry weight of bacteria after extraction.
4694 NEWELL ET AL. J. BACTERIOL.
fects of the gcbA and wspR mutations were additive, result-
ing in a modest but significant reduction compared the level for
the WT (P 	 0.002). The more pronounced effects of the
gcbB and gcbC mutations also were additive, with the gcbB
gcbC mutant showing a 65% reduction relative to WT effects
(Fig. 8B). This defect was comparable to that exhibited by the
4DGC mutant, a 72% reduction, and the difference between
the 4DGC mutant and gcbB gcbC was not statistically
significant (P 	 0.15).
The LapA localization results are interesting, because the
degree of reduction in cell surface LapA exhibited by each
single mutant does not strictly follow its effect on biofilm for-
mation. This observation is consistent with DGCs GcbA and
WspR affecting biofilm formation through outputs other than
LapA. Furthermore, the deletion of gcbB and gcbC seems to be
sufficient to explain the bulk of the c-di-GMP-dependent lo-
calization of LapA to the cell surface.
Effect of DGC gene deletions on swimming motility. As
described above, single deletions of either gcbA or gcbC caused
an increase in swimming motility compared to that of the WT
(Fig. 1D and 6E). We evaluated all single mutants, select
double mutants, and the 4DGC mutant for effects on swim-
ming through semisolid agar (Fig. 8C). In this assay, the wspR
and gcbB mutations were found to have minimal effects on
motility, with 4 and 19% increases, respectively, in swim area
compared to the level for the WT. The gcbC and gcbA
mutations caused more substantial increases in swim area: 46
and 81%, respectively. For all mutants except wspR, swim
FIG. 8. Combinatorial analysis of DGC mutants. (A) A quantitative biofilm assay comparing each single-, double-, triple-, and quadruple-
mutant combination for the DGC genes indicated (means 
 SD; n 	 8). (B) A quantitative immunoblot assay probing whole cells for the surface
expression of LapA by the indicated strains. Data shown are means 
 SE (n 	 7). Representative images are shown above the graph.
(C) Quantitative swimming motility assay for the strains indicated. Data presented are mean percentages of WT swim area on the same plate 

SE (n 	 8). Representative images of each mutant and adjacent WT control are shown above the corresponding bar in the graph.
VOL. 193, 2011 DIGUANYLATE CYCLASES AND P. FLUORESCENS Pf0-1 BIOFILMS 4695
areas proved to be statistically different from that of the WT
(P  0.01).
Double mutants were analyzed for swimming motility by
combining mutations that have the smallest or greatest effect
on the phenotype of interest, similarly to the rationale for
analyzing LapA localization. Both the gcbB wspR and
gcbA gcbC strains showed additive phenotypes in the swim-
ming motility assay compared to their single-mutant counter-
parts. The gcbA gcbC mutant showed a 120% increase in
swim area compared to that of the WT, which is comparable to
the 100% increase exhibited by the 4DGC mutant. The swim
zone areas exhibited by these two strains, gcbA gcbC and
4DGC, were not statistically different (P 	 0.15), suggesting
that gcbA and gcbC are sufficient to account for the regulation
of swimming motility by DGCs under the tested conditions.
DISCUSSION
In this study, we sought to determine which DGCs promote
biofilm formation by P. fluorescens Pf0-1. We found that, out of
30 predicted DGCs, mutations in only 4 caused significant
reductions in biofilm formation under the conditions tested.
The genetic and biochemical evidence presented here is con-
sistent with the conclusion that these proteins function as
DGCs in vivo. Mutations in five genes caused increases in
biofilm formation above the WT level, suggesting that they
encode tandem GGDEF/EAL domain proteins with c-di-GMP
phosphodiesterase activity.
Of the DGCs characterized here, gcbB and gcbC are pre-
dominantly responsible for promoting LapA localization to the
cell surface, a critical step for the transition to stable surface
attachment and subsequent biofilm formation (13, 14, 33). We
also found that the swimming motility of P. fluorescens Pf0-1 is
inhibited by DGCs, mainly gcbA and gcbC. These data raise the
possibility that biofilm formation by this organism is affected by
changes in motility, in addition to adherence via LapA. Further
experimentation is required to determine whether gcbA and
gcbC affect motility and biofilm formation independently or if
the modulation of motility contributes to their role(s) in bio-
film formation. The possibility that motility regulation does
affect biofilm formation by P. fluorescens Pf0-1 is consistent
with a growing consensus that biofilm initiation results from
the combined consequences of a reduction motility and in-
crease in adhesion (34). Dissecting the mechanistic basis for
the observed specificity in the outputs of gcbA and gcbB (mo-
tility and LapA localization, respectively) may help solve a
broader puzzle in c-di-GMP research: how are independent
c-di-GMP signals segregated and/or integrated in the cell?
We chose to focus our study on biofilm formation in one
growth medium, K10T-1. Further investigation will be required
to identify which parameters of this growth condition serve to
activate the DGCs characterized here. Surveying additional
growth conditions may reveal roles for other GGDEF domain
proteins in biofilm formation and consequently facilitate the
identification of specific signals for additional putative DGCs.
While it was not the focus of this study, it is interesting that
more PDEs than DGCs may regulate biofilm formation under
the conditions tested. Four predicted DGC mutants had sig-
nificant phenotypes, while five mutants in genes encoding pre-
dicted, tandem GGDEF/EAL proteins showed significant in-
creases in biofilm formation. An additional 11 candidate PDEs
were not examined here, leaving open the possibility that yet
more PDEs could affect biofilm formation by P. fluorescens
Pf0-1. This observation suggests that keeping c-di-GMP pro-
duction in check through robust PDE activities plays an im-
portant part in biofilm regulation by this organism, although
additional work will be required to test this hypothesis. Rainey
and colleagues have made an analogous finding while examin-
ing the mutational activation of the wrinkly spreader pheno-
type of P. fluorescens SBW25. Their work highlights that the
negative regulation of c-di-GMP production is common, and
the inactivation of negative regulators of DGC activity has
dramatic phenotypic consequences (21).
c-di-GMP promotes adherence and inhibits motility in an
array of different bacterial species. The commonality of this
observation is in contrast to the overwhelming diversity of
c-di-GMP signaling pathways and proteins employed within
and among bacterial species. In some groups, particularly the
gammaproteobacteria (45), it seems that each species or even
each strain has a unique complement of dozens of c-di-GMP
signaling proteins. For example, Pseudomonas fluorescens
Pf0-1 contains 43 proteins with either GGDEF or EAL or both
domains. Of these, 12 are not shared among the three com-
pleted P. fluorescens genomes (including gcbC), and just 10
have close homologues in four or more Pseudomonas species
(unpublished observations).
Both wspR and gcbA belong to the latter group, having
homologues in most Pseudomonas species. The hyperactiva-
tion of WspR through mutations to inhibitory components of
the Wsp chemosensory system causes the potent stimulation of
biofilm or pellicle formation in multiple pseudomonads (3, 12)
and the inhibition of motility in P. aeruginosa PAO1 (6). How-
ever, the inactivation of wspR alone showed subtle or no effect
on WT phenotypes in the same studies. One recent study of P.
fluorescens F113 reports increased swimming motility in wspR
mutants compared to that of the WT (30). Our data indicate
that wspR makes a small but measurable contribution to bio-
film formation by P. fluorescens Pf0-1 but has no effect on
swimming and a limited impact on LapA localization. The
identification of a growth condition or environmental signal
that activates the Wsp pathway and increases its impact on
biofilm formation by Pf0-1 above that observed in our test
conditions could provide an opportunity to further clarify its
role in this strain.
Much less is known about homologues of gcbA than those of
wspR. One study utilizing P. aeruginosa PAO1 shows a 40%
reduction in biofilm formation for a mutant with a transposon
insertion in PA4843 (51), a gcbA homologue. However, a gross
survey of c-di-GMP signaling genes in P. aeruginosa PA14
reported similar levels of biofilm formation for a PA4843 mu-
tant and the WT (17). Likewise, other exhaustive surveys of P.
aeruginosa PA14 mutants with reductions in biofilm formation
failed to identify PA4843 (28, 36). Any potential role for gcbA
homologues in regulating the flagellar motility of other bacte-
ria has not been reported.
If any conclusion can be drawn from comparing the pheno-
types of mutants in the same gene across different Pseudomo-
nas strains and species, it is that one should not assume that
conserved c-di-GMP signaling components serve an identical
function in different organisms. While conserved components
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may function similarly in different systems, these components
are likely to be pieced together differently within each organ-
ism’s unique c-di-GMP signaling repertoire. Finding common-
alities in the function and organization of analogous pathways
may be the key to understanding the underlying logic of these
signaling networks. By generating a detailed knowledge of
each signaling module and the role it plays in an individual
organism’s c-di-GMP network, we can build a broader under-
standing of how bacteria integrate signals to regulate biofilm
formation. This study represents a first step toward discerning
the architecture of c-di-GMP signaling in P. fluorescens Pf0-1,
a versatile model organism in which attachment to surfaces is
governed by a well-defined c-di-GMP effector system (31).
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